000			01713 a2200457 4500
005			20250513175735.0
264		0	_c19990520
008			199905s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aSaini, S S
245	0	0	_aDown-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cMay 1999
300			_a5624-30 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntibodies, Anti-Idiotypic _xadministration & dosage
650	0	4	_aBasophils _ximmunology
650	0	4	_aCells, Cultured
650	0	4	_aDown-Regulation _ximmunology
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHistamine _xblood
650	0	4	_aHistamine Release
650	0	4	_aHumans
650	0	4	_aImmunoglobulin E _xbiosynthesis
650	0	4	_aImmunoglobulin G _xphysiology
650	0	4	_aInfusions, Intravenous
650	0	4	_aLeukocyte Count
650	0	4	_aMale
650	0	4	_aReceptors, Antigen, B-Cell _xbiosynthesis
650	0	4	_aReceptors, IgE _xbiosynthesis
650	0	4	_aRespiratory Hypersensitivity _xtherapy
700	1		_aMacGlashan, D W
700	1		_aSterbinsky, S A
700	1		_aTogias, A
700	1		_aAdelman, D C
700	1		_aLichtenstein, L M
700	1		_aBochner, B S
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 162 _gno. 9 _gp. 5624-30
999			_c10187152 _d10187152